214 related articles for article (PubMed ID: 24951228)
1. Hepatocellular carcinoma in the noncirrhotic liver.
Gaddikeri S; McNeeley MF; Wang CL; Bhargava P; Dighe MK; Yeh MM; Dubinsky TJ; Kolokythas O; Lalwani N
AJR Am J Roentgenol; 2014 Jul; 203(1):W34-47. PubMed ID: 24951228
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
Burnett NP; Dunki-Jacobs EM; Callender GG; Anderson RJ; Scoggins CR; McMasters KM; Martin RC
Am Surg; 2013 Jul; 79(7):716-22. PubMed ID: 23816006
[TBL] [Abstract][Full Text] [Related]
3. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma in the noncirrhotic liver.
Smalley SR; Moertel CG; Hilton JF; Weiland LH; Weiand HS; Adson MA; Melton LJ; Batts K
Cancer; 1988 Oct; 62(7):1414-24. PubMed ID: 2843280
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasound pattern of hepatocellular carcinoma in noncirrhotic liver - results from the prospective multicentre DEGUM CEUS HCC study.
Schellhaas B; Jesper D; Strobel D;
Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):313-319. PubMed ID: 36708302
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules.
Jeong YY; Yim NY; Kang HK
AJR Am J Roentgenol; 2005 Oct; 185(4):1024-32. PubMed ID: 16177427
[TBL] [Abstract][Full Text] [Related]
9. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.
Trevisani F; D'Intino PE; Caraceni P; Pizzo M; Stefanini GF; Mazziotti A; Grazi GL; Gozzetti G; Gasbarrini G; Bernardi M
Cancer; 1995 May; 75(9):2220-32. PubMed ID: 7536121
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: Advances in diagnostic imaging.
Sun H; Song T
Drug Discov Ther; 2015 Oct; 9(5):310-8. PubMed ID: 26632539
[TBL] [Abstract][Full Text] [Related]
12. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
Park MJ; Kim YK; Lee MH; Lee JH
Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
[TBL] [Abstract][Full Text] [Related]
13. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma and other liver lesions.
Salgia R; Singal AG
Med Clin North Am; 2014 Jan; 98(1):103-18. PubMed ID: 24266917
[TBL] [Abstract][Full Text] [Related]
15. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers.
Okuda K; Nakashima T; Sakamoto K; Ikari T; Hidaka H; Kubo Y; Sakuma K; Motoike Y; Okuda H; Obata H
Cancer; 1982 Feb; 49(3):450-5. PubMed ID: 6277447
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.
Caroli-Bottino A; Nascimento CM; Basto S; Ribeiro J; Silveira V; Carvalho AM; Castro PN; Villela-Nogueiro CA; Pannain VL
Transplant Proc; 2005; 37(6):2791-2. PubMed ID: 16182811
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.
Zeng W; Gouw AS; van den Heuvel MC; Molema G; Poppema S; van der Jagt EJ; de Jong KP
Ann Surg Oncol; 2010 Jun; 17(6):1564-71. PubMed ID: 20087783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]